Answer
There are no data on nemolizumab excretion in human milk, and risk to the breastfed child cannot be excluded during the first few days after birth because IgG antibodies may transfer through milk; afterwards, nemolizumab could be used during breastfeeding if clinically needed.
Sources for this answer
- Nemluvio 30 mg powder and solvent for solution for injection in pre-filled penGalderma (U.K.) Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked